A Phase 1b Clinical Trial of LDE225 in Combination With Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX) in Previously Untreated Locally Advanced or Metastatic Pancreatic Adenocarcinoma, With an Expansion Cohort at the Recommended Phase 2 Dose.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Sonidegib (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions
- 20 Mar 2018 Planned End Date changed from 1 Apr 2018 to 1 Aug 2018.
- 20 Mar 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Aug 2018.
- 06 Apr 2017 Planned End Date changed from 1 Sep 2013 to 1 Apr 2018.